Literature DB >> 18049499

[Limbic encephalitis--a diagnostic challenge].

Anette Storstein1, Alla Bru, Christian A Vedeler.   

Abstract

BACKGROUND: The etiology of limbic encephalitis (LE) is often autoimmune. Autoimmune LE is often paraneoplastic and should be suspected in patients with subacute confusional states. Subgroups of LE require different treatment, and the prognosis is variable; making the correct diagnosis is therefore essential for a good outcome.
MATERIAL AND METHODS: The article is based on the authors' clinical experience with these patients and a review of recent literature retrieved from PubMed with the key words limbic encephalitis, limbic inflammation, paraneoplastic encephalitis, limbic and cancer, ion channel antibodies and viral encephalitis. Two case reports illustrate important clinical points. RESULTS AND
INTERPRETATION: Patients with LE constitute a heterogenous group with neuropsychiatric features, seizures and amnesia as the main symptoms. An early diagnosis is essential to limit sequelae. Viral encephalitis and Wernicke-Korsakoff Syndrome are important differential diagnoses. Presence of an onconeural antibody in serum is a specific tumour marker that should be used for screening all patients for malignancy. Not all cases of LE are paraneoplastic; ion channel antibodies can be an important marker for good response to immunosuppressive therapy in this group.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049499

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  2 in total

1.  Young girl with psychosis, cognitive failure and seizures.

Authors:  Imer Önder Slettedal; Hilde Margrete Dahl; Inger Sandvig; Josep Dalmau; Petter Strømme
Journal:  Tidsskr Nor Laegeforen       Date:  2012-10-02

2.  A case of limbic encephalitis presenting as a paraneoplastic manifestation of limited stage small cell lung cancer: a case report.

Authors:  Ahmed Fahim; Mohammad Butt; Damian V McGivern
Journal:  J Med Case Rep       Date:  2010-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.